Abstract

A Feasible Pathway for Open Access to Human Embryonic Stem Cell Patents<i>—</i>With China's Open License for Patent as the Entry Point

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call